Sarah J. Kurley

31-GEP Meta-analysis Supplementary Data

Bradley N. Greenhaw, Kyle R. Covington, Sarah J. Kurley, 2020 .

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.

Sarah J. Kurley, P. Meltzer, R. Schiff, 2014, The Journal of clinical investigation.

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Sarah J. Kurley, Lukas M. Simon, Ido Golding, 2015, Nature.

BUD31 and Lipid Metabolism: A New Potential Therapeutic Entry Point for Myc-Driven Breast Cancer

Sarah J. Kurley, S. Kurley, 2015 .

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

Sarah J. Kurley, Charles Y. Lin, C. Shaw, 2018, Nature Medicine.